Application of the SPR Biosensor in Drug Prototypes Discovery with Human Cytochrome P450(51) as an Example

Article Sidebar

pdf (Русский) html (Русский) html
Published: Nov 14, 2018
DOI: https://doi.org/10.18097/BMCRM00055
Keywords:
surface plasmon resonance (SPR); screening; human cytochrome P450(51); drug prototypes

Main Article Content

L.A. Kaluzhskiy
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
P.V. Ershov
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
T.V. Shkel
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, 5/2 Acad. Kuprevich str., Minsk, 220141 Belarus
O.V. Gnedenko
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia
N.V. Ivanchina
Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russian Academy of Sciences, 159, 100 Let Vladivostoka ave., Vladivostok, 690022 Russia
N.V. Strushkevich
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, 5/2 Acad. Kuprevich str., Minsk, 220141 Belarus
A.A. Kicha
Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russian Academy of Sciences, 159, 100 Let Vladivostoka ave., Vladivostok, 690022 Russia
I.P. Grabovec
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, 5/2 Acad. Kuprevich str., Minsk, 220141 Belarus
A.A. Gilep
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, 5/2 Acad. Kuprevich str., Minsk, 220141 Belarus
S.A. Usanov
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, 5/2 Acad. Kuprevich str., Minsk, 220141 Belarus
V.A. Stonik
Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russian Academy of Sciences, 159, 100 Let Vladivostoka ave., Vladivostok, 690022 Russia
A.S. Ivanov
Institute of Biomedical Chemistry, 10 Pogodinskaya str., Moscow, 119121 Russia

Abstract

The development of the integral platform “From Gene to Lead”, consolidated computer methods, bioinformatics researches, and experimental approaches, significantly accelerated and optimized base structure search in the field of drug design. The necessity of the experimental verification of hundreds virtual structure hypothesis (results of molecular data base selections or de novo construction) requires demands the usage of the high-through out and sensitive methods for validation possible interaction between numerous of selected compounds and particular molecular targets and evaluation of affinity, kinetics and thermodynamics. Surface plasmon resonance (SPR) technology makes it possible to solve all these problems. In this article the methodical aspects of the optical SPR-biosensor usage in the field of drug prototypes selection are described using the human cytochrome P450(51) catalyzing one of the key step of cholesterol biosynthesis as an example.

Article Details

How to Cite
Kaluzhskiy, L., Ershov, P., Shkel, T., Gnedenko, O., Ivanchina, N., Strushkevich, N., Kicha, A., Grabovec, I., Gilep, A., Usanov, S., Stonik, V., & Ivanov, A. (2018). Application of the SPR Biosensor in Drug Prototypes Discovery with Human Cytochrome P450(51) as an Example. Biomedical Chemistry: Research and Methods, 1(4), e00055. https://doi.org/10.18097/BMCRM00055
Issue
Vol. 1 No. 4 (2018)
Section
PROTOCOLS OF EXPERIMENTS, USEFUL MODELS, PROGRAMS AND SERVICES

References

  1. Ivanov, A.S., Veselovsky, A.V., Dubanov, A.V., Skvortsov, V.S. (2006). Bioinformatics platform development: from gene to lead compound. Methods in Molecular Biology, 316, 389-431. DOI
  2. Strushkevich, N., Usanov S.A., Park H.W. (2010) Structural basis of human CYP51 inhibition by antifungal azoles. Journal of Molecular Biology, 397(4), 1067-1078. DOI
  3. Gnedenko, O.V., Kaluzhskiy, L.A., Molnar, A.A., Yantsevich, A.V., Mukha, D.V., Gilep, A.A., Usanov, S.A., Stonik, V.A., Ivanov, A.S., Lisitsa, A.V., Archakov, A.I. (2013) The SPR-based biosensor test system for analysis of small compounds interaction with human cytochrome P450 51A1 (CYP51A1). Biochemistry (Moscow) Supplement. Series B, Biomedical Chemistry,7, 187–195. DOI
  4. Kaluzhskiy, L.A., Gnedenko, O.V., Gilep, A.A., Strushkevich, N.V., Shkel, T.V., Chernovetsky, M.A., Ivanov, A.S., Lisitsa, A.V., Usanov, A.S., Stonik, V.A., Archakov, A.I. (2014) Screening of human cytochrome P450(51) (CYP51A1) inhibitors: structural lanosterol analogues of plant and animal origin. Biochemistry (Moscow) Supplement. Series B, Biomedical Chemistry, 8, 349–360. DOI
  5. Kaluzhsky, L.A., Shkel, T.V., Ivanchina, N.V., Kicha, A.A., Grabovec, I.P., Gilep, A.A., Strushkevich, N.V., Chernovetsky, M.A., Medvedev, A.E., Usanov, S.A., Ivanov, A.S. (2017) Structural analogues of lanosterol from marine organisms of the class Asteroidea as potential inhibitors of human and Candida albicans lanosterol 14α-demethylases. Natural Product Communications, 12 (12), 1843-1846.
  6. Kicha, A.A., Kalinovsky, A.I., Levina, E.V., Stonik, V.A., Elyakov, G.B. (1983) Asterosaponin P1 from the starfish Patiria pectinifera. Tetrahedron Letters, 24, 3893–3896. DOI
  7. Kicha, A.A., Ivanchina, N.V., Gorshkova, I.A., Ponomarenko, L.P., Likhatskaya, G.N., Stonik, V.A. (2001) The distribution of free sterols, polyhydroxysteroids and steroid glycosides in various body components of the starfish Patiria (=Asterina) pectinifera. Comparative biochemistry and physiology. Part B, Biochemistry & Molecular Biology, 128, 43–52. DOI
  8. Kicha, A.A., Kalinovskii, A.I., Gorbach, N.V., Stonik, V.A. (1993) New polyhydroxysteroids from the Far Eastern sea star Henricia sp. Chemistry of Natural Compounds, 29, 206–210. DOI
  9. Kicha, A.A., Kalinovskii, A.I. (1993) Isolation of laeviuscoloside G from the starfish Henricia derjugini and correction of the structures of echinasterosides B1 and B2. Chemistry of Natural Compounds, 29, 547–548. DOI
  10. Kicha, A.A., Kapustina, I.I., Ivanchina, N.V., Kalinovsky, A.I., Dmitrenok, P.S., Stonik, V.A., Pal’yanova, N.V., Pankova, T.M., Starostina, M.V. (2008) Polyhydroxylated steroid compounds from the Far Eastern starfish Distolasterias nipon. Russian Journal of Bioorganic Chemistry, 34, 118–124. DOI
  11. Ivanchina, N.V., Kicha, A.A., Huong, T.T., Kalinovsky, A.I., Dmitrenok, P.S., Agafonova I.G., Long, P.Q., Stonik, V.A. (2010) Highly hydroxylated steroids of the starfish Archaster typicus from the Vietnamese waters. Steroids, 75, 897–904. DOI
  12. Myszka, D.G. (2000) Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE. Methods in Enzymology, 323, 325-340. DOI
  13. Ershov, P.V., Gnedenko, O.V., Molnar, A.A., Lisitsa, A.V., Ivanov, A.S., Archakov, A.I. (2012) Kinetic and thermodynamic analysis of dimerization inhibitors binding to HIV protease monomers by surface plasmon resonance. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 6(1), 94–97. DOI
  14. Trosken, E.R., Straube, E., Lutz, W.K., Volkel, W., Pattenm C. (2004) Quantitation of lanosterol and its major metabolite FF-MAS in an inhibition assay of CYP51 by azoles with atmospheric pressure photoionization based LC-MS/MS. Journal of the American Society for Mass Spectrometry, 15, 1216–1221. DOI
  15. Lepesheva GI, Waterman MR. (2007) Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochimica et Biophysica Acta General Subjects,1770, 467–477. DOI
  16. Lepesheva, G.I., Friggeri, L., Waterman, M.R. (2018) CYP51 as drug targets for fungi and protozoan parasites: past, present and future. Parasitology, 12, 1-17. DOI
  17. Gilli, P ., Gilli, G., Borea, P.A., Varani, K., Scatturin, A., Dalpiaz, A. (2005) Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors. Journal of Medicinal Chemistry, 48(6), 2026-2035. DOI